» Articles » PMID: 27555097

Physical Activity in Obese Type 2 Diabetes After Gastric Bypass or Medical Management

Overview
Journal Am J Med
Specialty General Medicine
Date 2016 Aug 25
PMID 27555097
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to compare effects of Roux-en-Y gastric bypass versus a multidisciplinary, group-based medical diabetes and weight management program on physical fitness and behaviors.

Methods: Physical behavior and fitness were assessed in participants of the study Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes (SLIMM-T2D) (NCT01073020), a randomized, parallel-group trial conducted at a US academic hospital and diabetes clinic with 18- to 24-month follow-up. Thirty-eight type 2 diabetes patients with hemoglobin A ≥6.5% and body mass index 30-42 kg/m were randomized to Roux-en-Y gastric bypass or the medical program. A 6-minute walk test to evaluate fitness, self-reported physical activity, standardized physical surveys, and cardiometabolic risk assessment were performed at baseline and after intervention.

Results: Both groups similarly improved 6-minute walk test distance, with greater improvements in oxygen saturation and reduced heart rate after surgery. Self-reported physical activity improved similarly at 18-24 months after interventions, although exercise increased gradually after surgery, whereas early substantial increases in the medical group were not fully sustained. Self-reported total and physical health were similar by Short Form-36 but improved more in the Impact of Weight on Quality of Life survey after surgery. Improvement in cardiovascular risk scores, HbA, and body mass index were greater after surgery.

Conclusion: In this small, randomized study, both interventions led to therapeutic lifestyle changes and improved objective and self-reported physical fitness. Greater improvements in heart rate, oxygen saturation, and perceived impact of weight on health were seen after surgery, which could be attributable to greater weight loss. The clinical importance of these improvements with greater weight loss warrants further investigation.

Citing Articles

Metabolic/Bariatric Surgery is Safe and Effective in People with Obesity, Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Cohen R, Azevedo M, le Roux C, Caldeon L, Luque A, Fayad D Obes Surg. 2024; 34(11):4097-4105.

PMID: 39417958 DOI: 10.1007/s11695-024-07535-4.


Role of the exercise professional in metabolic and bariatric surgery.

Stults-Kolehmainen M, Bond D, Richardson L, Herring L, Mulone B, Garber C Surg Obes Relat Dis. 2024; 20(1):98-108.

PMID: 38238107 PMC: 11311246. DOI: 10.1016/j.soard.2023.09.026.


Bariatric surgery, novel glucose-lowering agents, and insulin for type 2 diabetes and obesity: Bayesian network meta-analysis of randomized controlled trials.

Wu T, Wong C, Lui D, Wong S, Lam C, Chung M BJS Open. 2023; 7(4).

PMID: 37542473 PMC: 10404007. DOI: 10.1093/bjsopen/zrad077.


High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes control.

Dreyfuss J, Yuchi Y, Dong X, Efthymiou V, Pan H, Simonson D Nat Commun. 2021; 12(1):6951.

PMID: 34845204 PMC: 8630169. DOI: 10.1038/s41467-021-27289-2.


Quality of Life After Bariatric Surgery-a Systematic Review with Bayesian Network Meta-analysis.

Malczak P, Mizera M, Lee Y, Pisarska-Adamczyk M, Wysocki M, Bala M Obes Surg. 2021; 31(12):5213-5223.

PMID: 34633614 PMC: 8595157. DOI: 10.1007/s11695-021-05687-1.


References
1.
Halperin F, Ding S, Simonson D, Panosian J, Goebel-Fabbri A, Wewalka M . Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014; 149(7):716-26. PMC: 4274782. DOI: 10.1001/jamasurg.2014.514. View

2.
Naci H, Ioannidis J . Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ. 2014; 347:f5577. PMC: 3788175. DOI: 10.1136/bmj.f5577. View

3.
Schellenberg E, Dryden D, Vandermeer B, Ha C, Korownyk C . Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013; 159(8):543-51. DOI: 10.7326/0003-4819-159-8-201310150-00007. View

4.
Sadarangani K, Hamer M, Mindell J, Coombs N, Stamatakis E . Physical activity and risk of all-cause and cardiovascular disease mortality in diabetic adults from Great Britain: pooled analysis of 10 population-based cohorts. Diabetes Care. 2014; 37(4):1016-23. DOI: 10.2337/dc13-1816. View

5.
Wing R, Bolin P, Brancati F, Bray G, Clark J, Coday M . Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013; 369(2):145-54. PMC: 3791615. DOI: 10.1056/NEJMoa1212914. View